Establishing the cut-off point for the Candida swab test for daily oral care in dry mouth patients

Oral Therapeutics and Pharmacology

Volumn 28, Issue 1, 2009, Pages 17-25

  Kimori, Hisato ^a   Nakagawa, Yoichi ^a   Yamamoto, Ken ^a   Ohshima, Tomoko ^b  

^a University School of Dental Medicine

^b University School of Dental Medicine Candida

Author keywords

Candidiasis; Dry mouth; Risk assessment

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM DETECTION; CANDIDA; CHILD; CLINICAL FEATURE; COLONY FORMING UNIT; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MOUTH HYGIENE; MOUTH MUCOSA; PRESCHOOL CHILD; RISK FACTOR; SCHOOL CHILD; THROAT CULTURE; THRUSH; XEROSTOMIA;

EID: 65949087237     PISSN: 02881012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Dongari-Bagtzoglou A, et al.: The host cytokine responses and protective immunity in oropharyn-geal candidiasis. J Dent Res 2005, 84: 966-977.
2. Feng Z, et al.: Human beta-defensins: differential activity against candidal species and regulation by Candida albicans. J Dent Res 2005, 84: 445-450.
3. Sculluy C: Oral and maxillofacial medicine Edinburgh: Elsevier 2004.
4. Domergue R, et al.: Nicotinic acid limitation regulates silencing of Candida adhesins during UTI. Science 2005, 308: 866-870.
5. Green CB, et al.: RT-PCR detection of Candida albicans ALS gene expression in the reconstituted human epithelium (RHE) model of oral candidiasis and in model biofilms. Microbiology 2004, 150: 267-275.
6. Albrecht A, et al.: Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions. J Biol Chem 2006, 281: 688-694.
7. Jayatilake JA, et al.: An ultrastructural and a cytochemical study of candidal invasion of reconstituted human oral epithelium. J Oral Pathol Med 2005, 34: 240-246.
8. Kuriyama T. et al.: In vitro secreted aspartyl pro-teinase activity of Candida albicans isolated from oral diseases and healthy oral cavities. Oral Microbiol Immunol 2003, 18: 405-407.
9. Cannon RD, et al.: Oral Candida: clearance, colonization, or candidiasis? J Dent Res 1995, 74: 1152-1161.
10. Ellepola AN, et al: Oral candidal infections and antimycotics. Crit Rev Oral Biol Med 2000, 11: 172-198.
11. Williams DW, et al: Isolation and identification of Candida from the oral cavity. Oral Dis 2000, 6: 3-11.
12. Ken Y. et al.: The application of a night guard for sleep-related xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008, 106: e11-e14.
13. Whiting PF, et al.: Graphical presentation of diagnostic information. BMC Med Res Methodol 2008, 8: 20.
14. Arendorf TM, et al: The prevalence and intra-oral distribution of Candida albicans in man. Arch Oral Biol 1980, 25: 1-10.
15. Smith DE, et al: Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV. Aids 1991, 5:1367-1371.
16. Graybill JR, et al.: Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients. Am J Med 1998, 104: 33-39.
17. Vazquez JA, et al.: Efficacy of alcohol-based and alcohol-free melaleuca oral solution for the treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS. HIV Clin Trials 2002, 3: 379-385.